Ginkgo Bioworks Holdings, Inc.
DNA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $170M | $227M | −25.1% |
| Operating income | −$315M | −$560M | +43.7% |
| Net income | −$313M | −$547M | +42.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $27.7M | $29.4M | −5.8% |
| Operating income | −$43.6M | −$82.3M | +47.0% |
| Net income | −$41.0M | −$80.8M | +49.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Ginkgo Bioworks's revenue in FY2025?
- $170M in FY2025 (Fiscal year ended Dec 31, 2025), −25.1% vs $227M a year earlier, per its 10-K filed Feb 2026.
- Was Ginkgo Bioworks profitable in FY2025?
- No: net income was −$313M and operating income −$315M in FY2025.
- What was Ginkgo Bioworks's revenue in Q3 2026?
- $27.7M (−5.8% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.